Category: Senolytic News

Despite Their Scary Name, Some ‘Zombie’ Cells May Not Be All Bad

There’s a good zombie.

Read More

Focus on frailty: New senolytic holds potential for sarcopenia treatment

Buck Institute professor shifts focus to functional studies of senolytic compound with hopes for frailty and sarcopenia.

Read More

Progress in Emerging Alzheimer’s Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer’s Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer’s Disease Conference

The Alzheimer’s Drug Discovery Foundation will be moderating a session, “Beyond Amyloid and Tau: Emerging Solutions,” at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference, which will be...

Read More

Senolytic treatment shows promise in DME, wet AMD

FORT LAUDERDALE, Fla. — A senolytic therapy represents a novel approach to treating diabetic macular edema and wet age-related macular degeneration, according to a speaker at the Retina World Congress. Raj Maturi, MD, presented...

Read More

A Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice

Nature Communications – Monitoring the aging process in vivo is challenging. Here the authors generate a Glb1+/m‒Glb1-2A-mCherry (GAC) reporter mouse model, where the GAC signal is…

Read More

Global Senolytic Drugs Market Research Report 2022: Voice of Customer, Clinical Trials, Patent Analysis, Outlook, Market Dynamics, Trends & Developments, Competitive Landscape

Dublin, May 20, 2022 (GLOBE NEWSWIRE) — The “Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine…

Read More